Work

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth

Year: 2015

Type: article

Source: Oncogene

DOI: 10.1038/onc.2015.169

Authors: M M Morrison, M M Williams, D B Vaught, D Hicks, J Lim, C McKernan, L Aurisicchio, G Ciliberto, C Simion, C Sweeney, R S Cook

Institutions: Vanderbilt University, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Vanderbilt-Ingram Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Susan G. Komen, National Institutes of Health, National Cancer Institute

Awards: G1172811102, Mcl-1 drives resistance of luminal breast cancers to targeted therapies, G6555878713

OpenAlex ID: W1482373772

FWCI: 0.91

Cites: 36

Cited by: 18

Related to: 10